ClinConnect ClinConnect Logo
Search / Trial NCT06726304

Increasing Physical Contact Between Prenatally Anxious/Depressed Mothers and Their Infants to Improve Maternal Sensitivity.

Launched by SIR MORTIMER B. DAVIS - JEWISH GENERAL HOSPITAL · Dec 4, 2024

Trial Information

Current as of July 09, 2025

Not yet recruiting

Keywords

Baby Carrier Maternal Sensitivity Inter Personal Neural Synchrony Perinatal Anxiety Perinatal Depression

ClinConnect Summary

This clinical trial is looking at how using a baby carrier can help mothers who are feeling anxious or depressed during pregnancy. The main goal is to see if this increased physical contact with their infants can improve how sensitive mothers are to their baby's needs and strengthen the bond between them. The study will involve mothers choosing between two types of soft baby carriers and using them for a certain amount of time. They will also have two home visits and fill out questionnaires about their feelings and experiences with the baby carrier.

To participate, mothers must be at least 18 years old, able to communicate in English or French, and have been diagnosed with anxiety or depression during their pregnancy. They should also live in the greater Montreal area and have given birth to a healthy baby. Participants will be asked to share their thoughts on using the baby carrier through interviews, helping researchers understand the impact of physical contact on both the mother and baby. This trial is not yet recruiting participants, but it aims to gather valuable information that could help improve support for mothers facing these challenges.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • 18 years or older
  • be able to communicate in English or French
  • diagnosed with a depressive or anxiety disorder (or both) during their intake visit within the Perinatal Multisite Databank (PMD)
  • residing in the greater Montreal area
  • have given birth to a healthy baby
  • Exclusion Criteria:
  • having known alcohol or substance use issues,
  • having been diagnosed with psychosis or schizophrenia during the PMD intake assessment, or have had thoughts of harming the self or the baby
  • having physical restrictions that may prevent the regular use of a baby carrier
  • taking any medications regularly that cause potential participants to feel drowsy or dizzy
  • already using a baby carrier with their current baby for more than 5 hours a week

About Sir Mortimer B. Davis Jewish General Hospital

Sir Mortimer B. Davis – Jewish General Hospital is a leading academic medical center located in Montreal, Canada, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical research, the hospital integrates cutting-edge scientific inquiry with comprehensive patient care, focusing on a range of medical disciplines to enhance treatment outcomes and improve patient quality of life. With a strong emphasis on collaboration, ethics, and community engagement, the hospital strives to foster a research environment that promotes discovery and translates findings into effective therapeutic solutions.

Locations

Montreal, Quebec, Canada

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported